Exelixis (EXEL) Total Debt (2010 - 2017)
Exelixis' (EXEL) quarterly Total Debt came in at $113.3 million in Q1 2017, up 5.44% year-on-year from $107.5 million in Q1 2016, and up 3.87% quarter-over-quarter from $109.1 million in Q4 2016.
Exelixis (EXEL) Total Debt (2010 - 2017) Analysis & Trends
Exelixis' Total Debt history runs 8 years deep, the most recent figure standing at $113.3 million for Q1 2017.
- On a quarterly basis, Total Debt rose 5.44% year-over-year to $113.3 million in Q1 2017; TTM through Mar 2017 was $113.3 million, a 5.44% increase from a year earlier, with the FY2016 full-year figure at $109.1 million, up 36.4% from the prior year.
- Total Debt rose to $113.3 million in Q1 2017 per EXEL's latest filing, from $109.1 million in the prior quarter.
- Across five years, Total Debt topped out at $177.4 million in Q4 2014 and bottomed at $27.5 million in Q2 2016.
- The 5-year median for Total Debt is $90.8 million (2013), against an average of $99.0 million.
- Across the five-year window, Total Debt surged 96.45% in 2014 and slumped 65.62% in 2016, its largest moves.
- Year by year, Total Debt stood at $90.3 million in 2013, then jumped by 96.45% to $177.4 million in 2014, then tumbled by 54.92% to $80.0 million in 2015, then surged by 36.4% to $109.1 million in 2016, then grew by 3.87% to $113.3 million in 2017.
- Per Business Quant, the three latest EXEL Total Debt figures stand at $113.3 million (Q1 2017), $109.1 million (Q4 2016), and $29.4 million (Q3 2016).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 113.35 Mn |
| Dec 30, 2016 | 109.12 Mn |
| Sep 30, 2016 | 29.37 Mn |
| Jun 30, 2016 | 27.50 Mn |
| Mar 31, 2016 | 107.50 Mn |
| Dec 31, 2015 | 80.00 Mn |
| Sep 30, 2015 | 80.45 Mn |
| Jun 30, 2015 | 80.00 Mn |
| Mar 31, 2015 | 83.91 Mn |
| Dec 31, 2014 | 177.45 Mn |
| Sep 30, 2014 | 176.50 Mn |
| Jun 30, 2014 | 174.26 Mn |
| Mar 31, 2014 | 80.22 Mn |
| Dec 31, 2013 | 90.33 Mn |
| Sep 30, 2013 | 90.76 Mn |
| Jun 30, 2013 | 91.13 Mn |
| Mar 31, 2013 | 91.61 Mn |
| Dec 31, 2012 | 92.09 Mn |
| Sep 30, 2012 | 92.89 Mn |
| Jun 30, 2012 | 93.68 Mn |